Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 31, 2015 4:48 AM ET

Healthcare Providers and Services

Company Overview of Mayo Clinic

Company Overview

Mayo Clinic, a not-for-profit medical organization, provides medical care, research, and education services in Minnesota, Florida, Arizona, Iowa, Georgia, and Wisconsin. It offers medical care services in various specialties, including diabetes and endocrinology, gastroenterology, gynecology, cancer, neurology and neurosurgery, orthopedics, pulmonology, rheumatology, nephrology, urology, and cardiology and heart surgery. The company operates a network of care centers in the United States. It also provides medical education services through schools, offering various degree or certificate programs in continuing medical education, doctoral, master’s, and health sciences. In addition, the compan...

200 First Street SW

Rochester, MN 55905

United States

Founded in 1919

Phone:

507-284-2511

Fax:

507-284-0161

Key Executives for Mayo Clinic

Chief Executive Officer, President, Member of the Executive Board and Trustee
Age: 63
Chief Financial Officer
Vice President, Trustee and Chief Executive Officer of Mayo Clinic - Arizona
Vice President and Chief Executive Officer of Mayo Clinic Florida
Chief Administrative Officer, Vice President of Administration and Trustee
Compensation as of Fiscal Year 2015.

Mayo Clinic Key Developments

Diadexus And Mayo Clinic Join Forces On PLAC Activity Test to Improve Patient Care For Cardiovascular Diseases

Diadexus, Inc. and Mayo Clinic signed an agreement to collaborate in the areas of education, research, and innovation on the PLAC(r) Test for Lp-PLA2 Activity. The test, which has been cleared by the U.S. Food and Drug Administration, is used to help identify risk for coronary heart disease in patients with no history of cardiovascular events. As part of the agreement, Mayo Clinic's Department of Laboratory Medicine and Pathology will participate in the Diadexus Laboratory Partnership Program, where Diadexus will provide educational support during the proper integration and use of Lp-PLA2 Activity testing in the clinical practice. Once fully integrated, the test will be available to patients and providers worldwide through Mayo Clinic's reference laboratory Mayo Medical Laboratories, which offers advanced laboratory testing and pathology services to more than 5,000 health care organizations.

Gentag, Mayo Clinic, NovioSense and Fraunhofer Join Forces to Lower the Cost of Diabetes Care Globally

Building on the long-standing collaboration between Gentag and Mayo Clinic, and the long-standing collaboration between NovioSense and Fraunhofer Institute for Microelectronic Circuits and Systems (IMS), Gentag and NovioSense announced that they have formed a joint venture to combat the epidemic of type 2 diabetes that is overwhelming people and health care systems worldwide. Using their patented combined assets that include advanced chemistry knowledge, proprietary sensor designs, and software and chip (ASIC) design capabilities, the four parties will combine forces to develop a mobile-phone based platform to bring very low-cost, on-demand pain free diabetes monitoring to people worldwide. The technology will use consumers' Near Field Communication (NFC)-enabled smartphones as readers, replacing traditional glucometers. The joint venture is covered by 75 issued patents worldwide and is significantly lower cost than current type 2 diabetes solutions. Development will be carried out simultaneously on both sides of the Atlantic by NovioSense BV and Gentag, Inc., together with the diabetes teams from Mayo Clinic and the sensor and NFC teams of Fraunhofer IMS. The collaboration is a huge step forward in the commercialization of affordable, disposable diagnostic sensor systems powered by mobile phones. Gentag and NovioSense bring in unique technology platforms for low cost disposable diabetes sensors powered by any NFC enabled mobile phone or device. Mayo Clinic brings its medical expertise in diabetes and a global medical reach; it will write customized apps for diabetes monitoring applications. Fraunhofer brings its advanced sensor and chip design capabilities. The combined technology can be implemented for any diabetes application, including long-term implantable sensors, diabetes skin patches or eye (tear drop) sensors, or wireless insulin delivery systems controlled by mobile devices.

Mayo Clinic Presents at Piper Jaffray Heartland Summit, Jun-23-2015

Mayo Clinic Presents at Piper Jaffray Heartland Summit, Jun-23-2015 . Venue: Minneapolis, Minnesota, United States. Speakers: John H. Noseworthy, Chief Executive Officer, President, Member of The Executive Board and Trustee.

Similar Private Companies By Industry

Company Name Region
Advanced Service, Inc. United States
HRI Clinics, Inc. United States
Carolina Home Oxygen Medical Supply United States
Blue Cross Blue Shield Of Wyoming United States
Porter Hills Presbyterian Village, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
July 14, 2015
Welkin Health, Inc.
Private Placement
February 18, 2015
Lifecode, Inc.
Private Placement
October 7, 2014
Second Genome, Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Mayo Clinic, please visit www.mayoclinic.org. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.